UBS analyst Michael Goldsmith lowered the firm’s price target on Welltower (WELL) to $228 from $232 and keeps a Buy rating on the shares. 2026 is expected to mark a pivotal REIT turnaround, with forecast total returns of 9%-11% driven by improving macro conditions, attractive valuations, easing supply pressures, and a more stable political backdrop, the analyst tells investors in a research note. The outlook points to a bifurcated year with defensiveness in the first half of 2026 and stronger catalysts in the second half, favoring Healthcare, Shopping Centers, and Coastal Apartments, UBS says.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WELL:
- Welltower price target raised to $204 from $200 at Cantor Fitzgerald
- Welltower downgraded to Neutral from Overweight at JPMorgan
- Welltower price target raised to $231 from $210 at Jefferies
- Welltower price target raised to $232 from $203 at UBS
- Welltower price target raised to $218 from $200 at Wells Fargo